Calcium channel antagonist and beta‐blocker overdose: antidotes and adjunct therapies
Authors:
Open Access
- 7 September 2015
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 81 (3) , 453-461
Abstract
Management of cardiovascular instability resulting from calcium channel antagonist (CCB) or beta‐adrenergic receptor antagonist (BB) poisoning follows similar principles. Significant myocardial depression, bradycardia and hypotension result in both cases. CCBs can also produce vasodilatory shock. Additionally, CCBs, such as verapamil and diltiazem, are commonly ingested in sustained‐release formulations. This can also be the case for some BBs. Peak toxicity can be delayed by several hours. Provision of early gastrointestinal decontamination with activated charcoal and whole‐bowel irrigation might mitigate this. Treatment of shock requires a multimodal approach to inotropic therapy that can be guided by echocardiographic or invasive haemodynamic assessment of myocardial function. High‐dose insulin euglycaemia is commonly recommended as a first‐line treatment in these poisonings, to improve myocardial contractility, and should be instituted early when myocardial dysfunction is suspected. Catecholamine infusions are complementary to this therapy for both inotropic and chronotropic support. Catecholamine vasopressors and vasopressin are used in the treatment of vasodilatory shock. Optimizing serum calcium concentration can confer some benefit to improving myocardial function and vascular tone after CCB poisoning. High‐dose glucagon infusions have provided moderate chronotropic and inotropic benefits in BB poisoning. Phosphodiesterase inhibitors and levosimendan have positive inotropic effects but also produce peripheral vasodilation, which can limit blood pressure improvement. In cases of severe cardiogenic shock and/or cardiac arrest post‐poisoning, extracorporeal cardiac assist devices have resulted in successful recovery. Other treatments used in refractory hypotension include intravenous lipid emulsion for lipophilic CCB and BB poisoning and methylene blue for refractory vasodilatory shock.Keywords
This publication has 52 references indexed in Scilit:
- Methylene Blue in the Treatment of Refractory Shock From an Amlodipine OverdoseAnnals of Emergency Medicine, 2011
- Lipid rescue of massive verapamil overdose: a case reportJournal of Medical Case Reports, 2011
- Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsionEuropean Journal of Emergency Medicine, 2011
- Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical predictionBritish Journal of Pharmacology, 2007
- Insulin versus vasopressin and epinephrine to treat β-blocker toxicityClinical Toxicology, 2007
- Clinical review: Aggressive management and extracorporeal support for drug-induced cardiotoxicityCritical Care, 2007
- Pharmacology, Pathophysiology and Management of Calcium Channel Blocker and ??-Blocker ToxicityToxicological Reviews, 2004
- Insulin Improves Survival in a Canine Model of Acute β-Blocker ToxicityAnnals of Emergency Medicine, 1997
- A one-year evaluation of calcium channel blocker overdoses: Toxicity and treatmentAnnals of Emergency Medicine, 1993
- Recognition and management of poisoning with beta-adrenergic blocking agentsAnnals of Emergency Medicine, 1984